The potential inhibiton against enzymes target type 2 diabetes's pathways of leonuriside via virtual studies
Article Sidebar
Main Article Content
The potential inhibiton against enzymes target type 2 diabetes's pathways of leonuriside via virtual studies
Tóm tắt
Leonuriside (LN) is a natural compound previously purified from Euonymus laxiflorus Champ. and was found as a novel inhibitor of enzyme-targeting type 2 diabetes (T2D) treatment in our early reports via in vitro tests. This study aims to further characterize LN as a potential inhibitor of α-glucosidase and α-amylase and its high possibility of being developed as an antidiabetic drug via in silico studies. The result of the docking study indicated that LN could bind to targeting enzymes α-glucosidase (Q6P7A9) and α-amylase (1SMD) via forming stable complexes with acceptable root mean square deviation (RMSD) values (< 2.0Å) and good binding energy with low docking score (DS) values of -11.3 and -11.9 kcal/mol, respectively. The drug-likeness, and ADMET properties of LN were further investigated. The drug-likeness properties of LN were further investigated. The data of Lipinski’s rule of five analysis and absorption, distribution, metabolism, excretion and toxicity (ADMET)-based pharmacokinetics and pharmacology revealed that LN possesses all the properties fitting the requirement of Lipkin’s Rules and good ADMET properties in the required allotted limitation. The results obtained in this work suggested LN is a potential inhibitor of α-glucosidase and α-amylase and may be developed as a T2D drug.
Article Details
Tác phẩm này được cấp phép theo Giấy phép quốc tế Creative Commons Attribution-NonCommercial-NoDeri Phái sinh 4.0 .
Tài liệu tham khảo
- Chandra B.T.M., Rajesh S.S., Bhaskar B.V., Devi S., Rammohan A., Sivaraman T., Rajendra W (2017). Molecular docking, molecular dynamics simulation, biological evaluation and 2D QSAR analysis of flavonoids from Syzygium alternifolium as potent anti-Helicobacter pylori agents. RSC Advances, 7:18277–18292.
- DeMelo E.B., Gomes A., Carvalha I (2006). α-and β-Glucosidase inhibitors: Chemical structure and biological activity. J. Tetrahedr., 62:10277–10302
- Ding Y., Fang Y., Moreno J., Ramanujam J., Jarrell M., Brylinski M (2016). Assessing the similarity of ligand binding conformations with the contact mode score. Computational Biology and Chemistry, 64:403–413.
- Dirir A.M., Daou M., Yousef A.F., Yousef L.F (2021). A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochemistry Rev., 21(4):1049- 1079.
- Ghani U (2015). Re-exploring promising a-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. European Journal of Medicinal Chemistry, 103:133–162.
- Gligorić E., Igić R., Suvajdžić L., Grujić-Letić N (2019). Species of the Genus Salix, L.: Biochemical screening and molecular docking approach to potential acetylcholinesterase inhibitors. Applied Sciences, 9:1842.
- Kim Y., Wang M., Rhee M.J (2004). A novel alpha-glucosidase inhibitor from pine bark. Carbohydrate Research, 339:715–717.
- Liu L.M., Cheng S.F., Shieh P.C., Lee J.C., Chen J.J., Ho C.T., Kuo S.C., Kuo D.H., Huang L.J., Way T.D (2016). The methanol extract of Euonymus laxiflorus, Rubia lanceolata and Gardenia jasminoides inhibits xanthine oxidase and reduce serum uric acid level in rats. Food and chemical Toxicology, 70:179-84
- Loan H.T.P., Bui T.Q., My T.T.A., Hai N.T.T., Quang D.T., Tat P.V., Hiep D.T., Trung N.T., Quy P.T., Nhung N.T.A (2020). In-Depth Investigation of a Donor-Acceptor Interaction on the HeavyGroup-14@Group-13-Diyls in transition-metal tetrylone complexes: Structure, bonding, and property. ACS Omega, 5:21271–21287.
- Nguyen Q.V., Nguyen N.H., Wang L.W., Nguyen V.B., Nguyen A.D (2017). Free radical scavenging and antidiabetic activities of Euonymus laxiflorus Champ extract. Research on Chemical Intermediates, 43:5615–5624.
- Nguyen T.H., Wang S.L., Nguyen A.D., Doan M.D., Tran T.N., Doan C.T., Nguyen V.B (2022). Novel α-Amylase Inhibitor Hemi-Pyocyanin Produced by Microbial Conversion of Chitinous Discards. Marine Drugs, 20:283.
- Nguyen V.B., A.D., Kuo Y.H., Wang S.L (2017a). Biosynthesis of α-glucosidase inhibitors by a newly isolated bacterium, Paenibacillus sp. TKU042 and its effect on reducing plasma glucose in a mouse model. International Journal of Molecular Sciences,18:700.
- Nguyen V.B., Nguyen A.D., Nguyen Q.V., Wang S.L (2017b). Porcine pancreatic alpha-amylase inhibitors from Euonymus laxiflorus Champ. Research on Chemical Intermediates, 43:259-269.
- Nguyen V.B., Nguyen Q.V., Nguyen A.D., Wang L.W (2017c). Screening and evaluation of α-glucosidase inhibitors from indigenous medicinal plants in Dak Lak Province, Vietnam. Research on Chemical Intermediates, 43(6):3599–3612.
- Nguyen V.B., Wang S.L (2018a). New novel α-glucosidase inhibitors produced by microbial conversion. Process Biochemistry, 65:228–232.
- Nguyen V.B., Wang S.L. Nguyen A.D., Vo T.P.K.; Zhang L.J.; Nguyen Q.V. Kuo Y.H (2018c). Isolation and identification of novel α-amylase inhibitors from Euonymus laxiflorus Champ. Research on Chemical Intermediates 44:1411–1424.
- Nguyen V.B., Wang S.L., Nguyen T.H., Nguyen M.T., Doan C.T., Tran T.N., Lin Z.H., Nguyen Q.V., Kuo Y.H., Nguyen A.D (2018d). Novel Potent Hypoglycemic Compounds from Euonymus laxiflorus Champ. and Their Effect on Reducing Plasma Glucose in an ICR Mouse Model. Molecules, 23:1928.
- Nguyen V.B., Wang S.L., Phan T.Q., Pham T.H.T., Huang H.T., Liaw C.C., Nguyen A.D (2023). Screening and Elucidation of Chemical Structures of Novel Mammalian α-Glucosidase Inhibitors Targeting Anti-Diabetes Drug from Herbals Used by E De Ethnic Tribe in Vietnam. Pharmaceuticals, 16:756.
- Nguyen V.B., Wang, S.L., Nguyen A.D., Lin Z.H., Doan C.T., Tran T.N., Huang H.T., Kuo Y.H (2018b). Bioactivity-guided purification of novel herbal antioxidant and anti-NO compounds from Euonymus laxiflorus Champ. Molecules, 24:120.
- Rosenberg B (1962). Electrical conductivity of proteins. Nature, 193:364–365.
- Sarukhanyan E., Shanmugam T.A., Dandekar T. (2022). In Silico Studies Reveal Peramivir and Zanamivir as an Optimal Drug Treatment Even If H7N9 Avian Type Influenza Virus Acquires Further Resistance. Molecules, 27: 5920.
- Sato K., Nagai N., Yamamoto T., Mitamura K., Taga A (2019). Identification of a Novel Oligosaccharide in Maple Syrup as a Potential Alternative Saccharide for Diabetes Mellitus Patients. International Journal of Molecular Sciences, 20: 5041.